MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0351960

Медицинская библиотека · PloS one · 2026

Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan.

Kaidarova Saya, Mussazhanova Zhanna, Kozykenova Zhanna, Kurohama Hirokazu, Targynova Akbota, Dyussupov Altay, Yeleubayeva Zhanar, Nakashima Masahiro

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Autoimmune thyroiditis (AIT), including Hashimoto's thyroiditis (HT) and Graves' disease (GD), frequently coexists with papillary thyroid carcinoma (PTC). Chronic inflammation may influence thyroid carcinogenesis; however, the relationship between AIT and aggressive molecular alterations in PTC, particularly BRAFV600E and TERT promoter mutations, remains unclear. Data from iodine-deficient regions such as Kazakhstan are limited.

METHODS

We conducted a retrospective multicenter study of 231 patients with PTC from Kazakhstan treated between 2016 and 2020. Tumors were reclassified according to the World Health Organization 5th edition (2022). Clinicopathological characteristics, AIT status (HT and GD), BRAFV600E and TERT promoter mutation profiles, and proliferative activity (Ki-67) were analyzed. Associations between AIT, molecular alterations, and clinicopathological features were evaluated.

RESULTS

Most patients were female (83.1%) and <55 years (68.4%). AIT disease was present in 55.3% of cases, predominantly HT, while GD was uncommon (3.3%). BRAFV600E mutation alone was detected in 64.0% of patients, BRAF/TERT promoter co-mutation in 5.2%, TERT promoter mutation alone in 1.9%, and no mutations in 28.9%. TERT promoter-related mutations, particularly BRAF/TERT promoter co-mutations, were significantly more frequent in patients without AIT (p = 0.029) and were associated with lymph node metastasis, advanced tumor stage, older age, and larger tumor size. Patients with AIT had fewer aggressive molecular alterations. Patients with GD had higher Ki-67 labeling index and more aggressive clinicopathological features.

CONCLUSIONS

Different AIT subtypes showed distinct molecular and clinicopathological patterns in PTC. HT tended to demonstrate fewer aggressive molecular features, whereas GD showed features suggestive of increased proliferative activity. A lower prevalence of TERT promoter-related mutations was observed in AIT-positive patients, suggesting possible differences in molecular aggressiveness. However, these findings require validation in larger cohorts with broader molecular profiling.

Для цитирования: Kaidarova Saya, Mussazhanova Zhanna, Kozykenova Zhanna, Kurohama Hirokazu, Targynova Akbota, Dyussupov Altay, Yeleubayeva Zhanar, Nakashima Masahiro. Association between autoimmune thyroiditis and BRAFV600E/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan.. PloS one. 2026. DOI: 10.1371/journal.pone.0351960.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.